BioWorld MedTech

March 5, 2012

View Archived Issues

GE enhances web-based program for FHR monitoring education

Washington roundup: Registration fee exemptions to disappear in MDUFA III

Financings roundup: Vascular Magnetics raises $7M to develop PAD device

MDD's Fun Facts

Agreements/contracts: KCI wins 3-year single-source supply contract from Novation

Court report: Jury finds Illumina's Truseq kits infringe on LadaTech patents

ECR notebook: Riverain Technologies debuts new ClearRead software

Deals roundup: ConvaTec subsidiary set to acquire SureCalm Healthcare

Med-Tech Notes: Alere BP increases medication compliance

International report: Boston Sci launches Promus Element stent system in Japan

Product Briefs

MDD's Neurology Extra

European Congress of Radiology: Strong ultrasound growth attracts major new players

VIENNA Ultrasound is the hot growth area in medical technology, continuing to post double-digit growth year-to-year. A fact that has not escaped the attention of some very big players. Read More

The Israel Connection: Dealmaker's conference seeks to harness Israeli innovation

Today's news in brief

BioWorld

BioWorld briefs for Feb. 14, 2025.

European VCs optimistic for med-tech exit opportunities in 2025

BioWorld MedTech

To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Feb. 14, 2025

European VCs bullish on med-tech investments in 2025

BioWorld MedTech

European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...

3D illustration of acute myeloid leukemia cells

Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML

BioWorld

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...